In patients who undergo cardiac surgery, severe perioperative bleeding and its treatment are often associated with increases in major cardiac and non-cardiac adverse events and greater mortality. A study from the September issue of Anesthesiology determined certain blood clotting treatment algorithms helped decrease blood transfusion requirements in cardiac surgery patients and were associated with improved outcomes and hospital cost-savings.
The study used specific bedside testing -- so called "point-of-care testing," -- to examine the function of components of the blood clotting cascade, as well as platelet function to supplement clinical judgment in deciding on the best treatment. If abnormalities were detected, blood clotting components that were deficient were corrected based on treatment algorithms.
"We wanted to find the safest and most efficient way to provide hemostasic, or blood clotting, interventions in cardiac patients," said corresponding study author Klaus Görlinger, M.D. "Our clinical trial of 100 patients analyzed the effectiveness of blood clotting treatment algorithms based on point-of-care testing combined with administration of specific coagulation factor concentrates such as fibrinogen and prothrombin complex concentrate."